supp.fit

Shilajit: study protocols

11 study groups say how much Shilajit participants took a day. These are the doses the studies gave. They are not a recommendation.

Shilajit: what the research found →

Dose per serving from products

307 products in our catalogue print how much Shilajit a serving holds.

Most common: 250 mg to 500 mg, 34% of 307 products.

Dose per servingProducts
10 mg or less
7
10 mg to 25 mg
16
25 mg to 50 mg
18
50 mg to 100 mg
40
100 mg to 250 mg
46
250 mg to 500 mg
103
500 mg to 1 g
60
1 g to 2.5 g
9
over 2.5 g
8

Dose per serving from research

11 study groups in 6 studies say how much Shilajit participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 250 mg to 500 mg, 45% of 11 study groups.

Daily doseStudy groups
5 mg to 10 mg
1
10 mg to 25 mg
1
25 mg to 50 mg
0
50 mg to 100 mg
0
100 mg to 250 mg
3
250 mg to 500 mg
5
500 mg to 1 g
1

Commonly used together

2 of 11 study groups took Shilajit with something else, but nothing that 3 or more different studies gave.

11 study groups

Study
The effects of Shilajit supplementation on fatigue-induced decreases in muscular strength and serum hydroxyproline levels
2019 · High dose Shilajit · Recreationally trained men aged 21.2 ± 2.4 years with no known cardiovascular, pulmonary, metabolic, or musculoskeletal disease
500 mg8 weeks21
The effects of Shilajit supplementation on fatigue-induced decreases in muscular strength and serum hydroxyproline levels
2019 · Low dose Shilajit · Recreationally trained men aged 21.2 ± 2.4 years with no known cardiovascular, pulmonary, metabolic, or musculoskeletal disease
250 mg8 weeks21
Shilajit extract reduces oxidative stress, inflammation, and bone loss to dose-dependently preserve bone mineral density in postmenopausal women with osteopenia: A randomized, double-blind, placebo-controlled trial
2022 · 500 mg shilajit extract · Postmenopausal women aged 45–65 years with osteopenia
500 mg48 weeks—
Shilajit extract reduces oxidative stress, inflammation, and bone loss to dose-dependently preserve bone mineral density in postmenopausal women with osteopenia: A randomized, double-blind, placebo-controlled trial
2022 · 250 mg shilajit extract · Postmenopausal women aged 45–65 years with osteopenia
250 mg48 weeks—
Skin Transcriptome of Middle-Aged Women Supplemented With Natural Herbo-mineral Shilajit Shows Induction of Microvascular and Extracellular Matrix Mechanisms
2019 · Group 3 (S250) · Women aged 30–65 years; no specific condition reported
500 mg14 weeks15
Clinical evaluation of purified Shilajit on testosterone levels in healthy volunteers
2016 · Shilajit · Healthy men aged 45–55 years
500 mg90 days—
Effects of 8 Weeks of Shilajit Supplementation on Serum Pro-c1α1, a Biomarker of Type 1 Collagen Synthesis: A Randomized Control Trial
2024 · Low dose · Recreationally trained men; mean age 21.1 years; no condition stated
500 mg8 weeks—
Effects of 8 Weeks of Shilajit Supplementation on Serum Pro-c1α1, a Biomarker of Type 1 Collagen Synthesis: A Randomized Control Trial
2024 · High dose · Recreationally trained men; mean age 21.1 years; no condition stated
1 g8 weeks—
Skin Transcriptome of Middle-Aged Women Supplemented With Natural Herbo-mineral Shilajit Shows Induction of Microvascular and Extracellular Matrix Mechanisms
2019 · Group 2 (S125) · Women aged 30–65 years; no specific condition reported
250 mg14 weeks15
Effects of 12 Weeks of Chromium, Phyllanthus emblica Fruit Extract, and Shilajit Supplementation on Markers of Cardiometabolic Health, Fitness, and Weight Loss in Men and Women with Risk Factors to Metabolic Syndrome Initiating an Exercise and Diet Intervention: A Randomized Double-Blind, Placebo-Controlled Trial
2025 · Cr-800 · Sedentary men and women aged 30–65 with overweight/obesity and at least two risk factors for metabolic syndrome
12 mg12 weeks23
Effects of 12 Weeks of Chromium, Phyllanthus emblica Fruit Extract, and Shilajit Supplementation on Markers of Cardiometabolic Health, Fitness, and Weight Loss in Men and Women with Risk Factors to Metabolic Syndrome Initiating an Exercise and Diet Intervention: A Randomized Double-Blind, Placebo-Controlled Trial
2025 · Cr-400 · Sedentary men and women aged 30–65 with overweight/obesity and at least two risk factors for metabolic syndrome
6 mg12 weeks18